1
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: A Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/BLOODADVANCES.2021004295;
2021
2
Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S. P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie Jose, Durmaz, Mujde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G. E., van der Poel, Marjolein W. M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, Nijland, Marcel
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
Veröffentlicht in: Brink , M , Kahle , X U , Vermaat , J S P , Zijlstra , J M , Chamuleau , M , Kersten , M J , Durmaz , M , Plattel , W J , Lugtenburg , P J , Stevens , W , Mous , R , de Vries , E G E , van der Poel , M W M , Panday , P V N , Huls , G , van Meerten , T & Nijland , M 2021 , ' Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma : a Dutch population-based study ' , Blood , vol. 5 , no. 15 , pp. 2958-2964 . https://doi.org/10.1182/bloodadvances.2021004295;
2021
3
Raa, Doreen G.Te, van der Straten, Lina, van Gelder, Michel, Kersting, Sabina, Levin, Mark David, Mous, Rogier, van der Straaten, Hanneke M., Nijziel, Marten R., van der Spek, Ellen, Posthuma, Eduardus F.M., Visser, Hein P.J., van der Klift, Marjolein, de Heer, Koen, Bellido, Mar, Doorduijn, Jeanette K., Bruns, Anke H.W., Raijmakers, Reinier A.P., Kater, Arnon P.
Veröffentlicht in: HOVON CLL study group , Raa , D G T , van der Straten , L , van Gelder , M , Kersting , S , Levin , M D , Mous , R , van der Straaten , H M , Nijziel , M R , van der Spek , E , Posthuma , E F M , Visser , H P J , van der Klift , M , de Heer , K , Bellido , M , Doorduijn , J K , Bruns , A H W , Raijmakers , R A P & Kater , A P 2022 , ' Diagnosis, treatment and supportive management of chronic lymphocytic leukemia : recommendations of the Dutch HOVON CLL working group ' , Leukemia and Lymphoma , vol. 63 , no. 10 , pp. 2276-2289 . https://doi.org/10.1080/10428194.2022.2084731;
2022
Veröffentlicht in: HOVON CLL study group , Raa , D G T , van der Straten , L , van Gelder , M , Kersting , S , Levin , M D , Mous , R , van der Straaten , H M , Nijziel , M R , van der Spek , E , Posthuma , E F M , Visser , H P J , van der Klift , M , de Heer , K , Bellido , M , Doorduijn , J K , Bruns , A H W , Raijmakers , R A P & Kater , A P 2022 , ' Diagnosis, treatment and supportive management of chronic lymphocytic leukemia : recommendations of the Dutch HOVON CLL working group ' , Leukemia and Lymphoma , vol. 63 , no. 10 , pp. 2276-2289 . https://doi.org/10.1080/10428194.2022.2084731;
2022